[Opioid withdrawal following refilling of an implantable drug delivery system for intrathecal infusion].

Schmerz

Klinik für Schmerz- und Palliativmedizin, SRH Wald-Klinikum Gera GmbH, Straße des Friedens 122, 07548, Gera, Deutschland.

Published: January 2024

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00482-023-00779-6DOI Listing

Publication Analysis

Top Keywords

[opioid withdrawal
4
withdrawal refilling
4
refilling implantable
4
implantable drug
4
drug delivery
4
delivery system
4
system intrathecal
4
intrathecal infusion]
4
[opioid
1
refilling
1

Similar Publications

Background: Methadone maintenance treatment (MMT) is effective for treating opioid dependence. However, nonadherence can increase the risk of withdrawal syndrome, relapse, and overdose.

Methods: A community-based randomized controlled trial was conducted on 450 opioid-dependent patients undergoing MMT at three clinics in Ho Chi Minh City, Vietnam.

View Article and Find Full Text PDF

Finding new ways to treat overdoses.

Elife

January 2025

Department of Pharmaceutical Sciences, University of Kentucky, Lexington, United States.

Reversing opioid overdoses in rats using a drug that does not enter the brain prevents the sudden and severe withdrawal symptoms associated with therapeutics that target the central nervous system.

View Article and Find Full Text PDF

Large library docking of tangible molecules has revealed potent ligands across many targets. While make-on-demand libraries now exceed 75 billion enumerated molecules, their synthetic routes are dominated by a few reaction types, reducing diversity and inevitably leaving many interesting bioactive-like chemotypes unexplored. Here, we investigate the large-scale enumeration and targeted docking of isoquinuclidines.

View Article and Find Full Text PDF

Outpatient Low-Dose Initiation of Buprenorphine for People Using Fentanyl.

JAMA Netw Open

January 2025

San Francisco Department of Public Health, San Francisco, California.

Importance: The rise of high-potency opioids such as fentanyl makes buprenorphine initiation challenging due to the risks of precipitated withdrawal, prompting the exploration of strategies, such as low-dose initiation (LDI) of buprenorphine. However, no comparative studies on LDI outcomes exist.

Objective: To evaluate outpatient outcomes associated with 2 LDI protocols of buprenorphine among individuals with opioid use disorder (OUD) using fentanyl.

View Article and Find Full Text PDF

The opioid crisis, driven by synthetic opioids like fentanyl, demands innovative solutions. The opioid antidote naloxone has a short action ( ~ 1 hour), requiring repeated doses. To address this, we present a new and simple naloxone prodrug delivery system repurposing a hydrophilic derivative of acoramidis, a potent transthyretin ligand.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!